Partisan Management Group Inc.
This article was originally published in Start Up
Executive Summary
The strategy of Partisan Management Group Inc. is simple; reliance on a small circle of talented, experienced friends to build fledgling medical device companies. Led by Norman Weldon, PhD, and Karen Cassidy, it works. Partisan, an early-stage venture capital investment group which focuses strictly on seed funding for medical device start-ups, has produced a series of solid gains for its investors, twice scoring what anyone in the industry would consider to be home runs.
You may also be interested in...
Awaiting The Part D Shakeout
The Medicare drug benefit has more plans and fewer enrollees than expected. That is a recipe for consolidation, but will the federal government wait for the market to evolve?
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.